JUNS
Jupiter Neurosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.28
+0.61%Forward multiples
Based on analyst estimates
- P/E forward
- 2.19x
- P/E 2026E
- 0.74x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.30x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -11.82x
- Price / sales
- 66.85x
- Price / cash flow
- -0.60x
Enterprise value
- Enterprise value
- $4.6M
- EV / sales
- 70.36x
- EV / EBITDA
- -0.48x
- EV / EBIT
- -0.46x
- Market cap
- $4.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026